416 related articles for article (PubMed ID: 32859768)
1. Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls.
Filippov MA; Tatarnikova OG; Pozdnyakova NV; Vorobyov VV
Neural Regen Res; 2021 Feb; 16(2):223-233. PubMed ID: 32859768
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Mitochondrial Dysfunction: A Potential Contributor to the Development of Metabolic Disorders and Alzheimer's Disease.
Sultana MA; Hia RA; Akinsiku O; Hegde V
Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508448
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus.
Veselov IM; Vinogradova DV; Maltsev AV; Shevtsov PN; Spirkova EA; Bachurin SO; Shevtsova EF
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833898
[TBL] [Abstract][Full Text] [Related]
5. Riding the tiger - physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix.
Brand MD
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):592-661. PubMed ID: 33148057
[TBL] [Abstract][Full Text] [Related]
6. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial-Targeted Catalase: Extended Longevity and the Roles in Various Disease Models.
Dai DF; Chiao YA; Martin GM; Marcinek DJ; Basisty N; Quarles EK; Rabinovitch PS
Prog Mol Biol Transl Sci; 2017; 146():203-241. PubMed ID: 28253986
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.
Mi Y; Qi G; Brinton RD; Yin F
Antioxid Redox Signal; 2021 Mar; 34(8):611-630. PubMed ID: 32143551
[No Abstract] [Full Text] [Related]
9. Apoe4 and Alzheimer's Disease Pathogenesis-Mitochondrial Deregulation and Targeted Therapeutic Strategies.
Pires M; Rego AC
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614219
[No Abstract] [Full Text] [Related]
10. Mitochondrial Disorders in Alzheimer's Disease.
Sukhorukov VS; Mudzhiri NM; Voronkova AS; Baranich TI; Glinkina VV; Illarioshkin SN
Biochemistry (Mosc); 2021 Jun; 86(6):667-679. PubMed ID: 34225590
[TBL] [Abstract][Full Text] [Related]
11. Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights.
Oliyaei N; Moosavi-Nasab M; Tanideh N; Iraji A
Brain Res Bull; 2023 Feb; 193():11-21. PubMed ID: 36435362
[TBL] [Abstract][Full Text] [Related]
12. The Role of Bioenergetics in Neurodegeneration.
Strope TA; Birky CJ; Wilkins HM
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012480
[TBL] [Abstract][Full Text] [Related]
13. Advances in fucoxanthin chemistry and management of neurodegenerative diseases.
Li N; Gao X; Zheng L; Huang Q; Zeng F; Chen H; Farag MA; Zhao C
Phytomedicine; 2022 Oct; 105():154352. PubMed ID: 35917771
[TBL] [Abstract][Full Text] [Related]
14. Monoamine Oxidase-Related Vascular Oxidative Stress in Diseases Associated with Inflammatory Burden.
Sturza A; Popoiu CM; Ionică M; Duicu OM; Olariu S; Muntean DM; Boia ES
Oxid Med Cell Longev; 2019; 2019():8954201. PubMed ID: 31178977
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's Disease and Inflammaging.
Kosyreva AM; Sentyabreva AV; Tsvetkov IS; Makarova OV
Brain Sci; 2022 Sep; 12(9):. PubMed ID: 36138973
[TBL] [Abstract][Full Text] [Related]
16. Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation.
Silva DF; Empadinhas N; Cardoso SM; Esteves AR
Antioxidants (Basel); 2022 Oct; 11(11):. PubMed ID: 36358513
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!
Cardoso SM; Correia SC; Carvalho C; Moreira PI
Handb Exp Pharmacol; 2017; 240():281-308. PubMed ID: 28251365
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease and type 2 diabetes mellitus: similarities in pathomechanisms lead to therapeutic opportunities.
Bednarz K; Siuda J
Neurol Neurochir Pol; 2021; 55(5):418-428. PubMed ID: 34355790
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory Effect of Astaxanthin on Oxidative Stress-Induced Mitochondrial Dysfunction-A Mini-Review.
Kim SH; Kim H
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30134611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
